Chromosomal instability (CIN) is a hallmark of malignant evolution that underpins cancer progression and therapeutic evasion. There are few established experimental systems to study CIN and ultimately develop potential therapeutic options. A new study now identifies the MSL chromatin complex as a potential vulnerability against CIN in cancer cells.
References
McDonald 3rd, E. R. et al. Cell 170, 577–592.e10 (2017).
Tsherniak, A. et al. Cell 170, 564–576.e16 (2017).
Josep, M. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-021-00657-2 (2021).
Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Nat. Rev. Mol. Cell Biol. 11, 220–228 (2010).
Sheikh, B. N. & Akhtar, A. Nat. Rev. Genet. 20, 7–23 (2019).
Scaffidi, P. & Misteli, T. Nat. Cell Biol. 13, 1051–1061 (2011).
Ben-David, U. & Amon, A. Nat. Rev. Genet. 21, 44–62 (2020).
Shogren-Knaak, M. et al. Science 311, 844–847 (2006).
Groth, A., Rocha, W., Verreault, A. & Almouzni, G. Cell 128, 721–733 (2007).
Clemente-Ruiz, M. et al. Dev. Cell 36, 290–302 (2016).
Baell, J. B. et al. Nature 560, 253–257 (2018).
MacPherson, L. et al. Nature 577, 266–270 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.A.D. has been a member of advisory boards for GlaxoSmithKline, CTX CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix. The M.A.D. laboratory received research funding from CTx CRC.
Rights and permissions
About this article
Cite this article
Motazedian, A., Dawson, M.A. MSL pushes genomic instability over the edge. Nat Cell Biol 23, 295–296 (2021). https://doi.org/10.1038/s41556-021-00666-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-021-00666-1
- Springer Nature Limited